Magnesia phosphorica 30c homeopathic tablets
Available from pharmacies, supermarkets, and retail outlets
Official documents, adverse reaction reporting, and safety monitoring
Report a side effect
Submit a Yellow Card report to the MHRA
Safety monitoring data
Yellow Card reports
The MHRA Yellow Card scheme collects reports of suspected side effects from healthcare professionals and patients. View the Drug Analysis Profile (iDAP) for real-world adverse reaction data.
View Drug Analysis Profile
Browse all Drug Analysis Profiles A–Z
Browse all iDAP reports
Interactive Drug Analysis Profiles for all medicines
Report a side effect
Submit a Yellow Card report to the MHRA
Data from the MHRA Yellow Card scheme. A reported reaction does not necessarily mean the medicine caused it. Contains public sector information licensed under the Open Government Licence v3.0.
EudraVigilance
The European Medicines Agency (EMA) collects suspected adverse reaction reports from across the EU/EEA through the EudraVigilance system. Search for safety data on this medicine.
Search EudraVigilance database
Browse substances A–Z in the European adverse reaction database
About EudraVigilance
Learn about EU pharmacovigilance and safety monitoring
EudraVigilance data is published by the European Medicines Agency (EMA). A suspected adverse reaction is not necessarily caused by the medicine.
1 branded products available
MHRA licensed products
View all licensed products for Homeopathic magnesia phosphorica on the MHRA register
Magnesium phosphoricum 30c homeopathic tablets
Therapeutically similar medicines
Similarity is based on WHO Anatomical Therapeutic Chemical (ATC) classification and on a factual NHS dm+d therapeutic-grouping code prefix. Source data: NHS dm+d via TRUD (OGL v3.0), WHO ATC/DDD Index.
NHS prescribing volume and spending trends
Check stock at pharmacies and supply information
Pharmacy stock checkers
Search for this medicine at major UK pharmacy chains. These links open the retailer's own website — results depend on their current online catalogue.
Supply & safety information
Official UK regulator monitoring and safety alerts
Pharmacy links redirect to the retailer's own search and do not represent real-time stock levels. Shortage and safety information sourced from MHRA drug safety updates (gov.uk, Crown Copyright under OGL v3.0).
Codes for healthcare professionals and prescribing systems
These codes are used by healthcare IT systems and prescribers to identify this medicine.
NHS UK identifiers
SNOMED CT and dm+d codes from NHS TRUD (Technology Reference data Update Distribution), licensed under the Open Government Licence v3.0. BNF code shown is the factual mapping value distributed by NHS Business Services Authority (NHSBSA) in the dm+d supplementary file under OGL v3.0; it is not affiliated with, nor licensed from, the publishers of the British National Formulary.
Active and completed clinical studies from ClinicalTrials.gov
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine (NLM), National Institutes of Health (NIH). Data accessed via ClinicalTrials.gov API v2. Trial information is provided for research purposes and does not constitute medical advice.
Academic studies and reviews for this medicine's active substance
Showing all 19 studies.
Reviews & meta-analyses: 4 · Randomised trials: 1 · 2016–2026
Showing all 19 studies, sorted by most relevant.
Denis Arsovski, Natasha Chichevska-Jovanova
Timisoara Physical Education and Rehabilitation Journal, 2025
Abstract Introduction. Cerebral palsy is a non-progressive neurological disorder that impacts motor and functional development of the affected children. While physiotherapy and pharmacologic interventions remain standard, families explore homeopathy as a complementary option. This review examines the current evidence supporting the use of homeopathy in pediatric cerebral palsy rehabilitation. Aims. To assess the quality, safety, and reported effects of homeopathic treatments in children with cerebral palsy and determine whether such approaches can be integrated into rehabilitative practice. Material and method. A systematic literature review was conducted following preferred reporting items for systematic reviews and meta-analysis. Databases searched included PubMed, Scopus, Cochrane, Google Scholar, and ScienceDirect. Eligibility criteria were specified using the PICOS framework, with particular emphasis on pediatric populations diagnosed with cerebral palsy who received either personalized or complex homeopathic interventions. Out of 257 initial records, 46 studies met inclusion criteria for narrative synthesis. Due to methodological heterogeneity, no meta-analysis was performed. Results. Frequent reports cited improvements in muscle tone, sleep, appetite, emotional regulation, and behavioral outcomes. Common remedies included Calcarea phosphorica, Belladonna, Stramonium, and Zincum metallicum. However, most findings originated from case reports and observational studies with limited methodological rigor. Risks include delayed access to evidence-based treatment and variable remedy quality. Conclusion. While some families and clinicians notice benefits from homeopathy, the current evidence base lacks the rigor necessary to recommend it as proven alternative therapy for cerebral palsy. High-quality randomized controlled trials are urgently needed. Until then, homeopathy should be approached with caution and only within integrative care models under clinical supervision.
Abstract licence: CC BY-NC-ND
Shruti Rai, G. N. Gupta, Subhas Singh, et al.
Homeopathy : the journal of the Faculty of Homeopathy, 2022
- Acne Vulgaris
- Homeopathy
- Materia Medica
Renu Tripathi, Anoop Choudhary
International Journal of Homoeopathic Sciences, 2025
Abhishek Kumar
Bhartiya Krishi Anusandhan Patrika, 2025
Homeopathy has been increasingly investigated as a complementary approach in the management of reproductive disorders in livestock. Several studies in dairy cattle and buffaloes have demonstrated the efficacy of homeopathic complexes, administered in various potencies (e.g., 30C, 200C, 6C, 30X and MK), in managing conditions such as true anoestrus, ovarian inactivity, cystic ovarian disease, postpartum anestrus and endometritis. These remedies, including Calcarea phosphorica, Sepia, Pulsatilla, Aletris farinosa and Oophorinum, appear to exert regulatory effects on the hypothalamic-pituitary-gonadal (HPG) axis, improving ovarian cyclicity, estrus induction and conception rates. Additionally, some homeopathic formulations have shown potential in modulating mineral metabolism, supporting follicular development and restoring hormonal balance. Beyond female fertility, emerging evidence highlights the potential role of homeopathy in enhancing male fertility by improving mitochondrial bioenergetics, sperm motility and semen quality. Complexes such as Ubichinon compositum®, Coenzyme compositum® and individualized remedies like Sulphur, Phosphorus, Lycopodium, Argentum nitricum and Pulsatilla have demonstrated promising effects on sperm function and cryopreservation outcomes in bulls. Collectively, these findings suggest that homeopathy, through endocrine modulation, metabolic support and cellular bioenergetics enhancement, holds promise as a safe and viable alternative or adjunct therapy for improving reproductive performance in farm animals.
Abstract licence: CC BY
Abuzenada BM, Pullishery F, Elnawawy MSA, et al.
2021
Complementary and alternative medicine (CAM) uses a holistic approach that finds natural solutions that help the immune system to fight off infection and diseases. In conventional medicine, the diseases are treated as a series of symptoms developed and not its actual cause or etiology, but CAM commonly targets the exact cause of the disorder thereby stimulating the body's healing process. This is based on an integrative literature review of methods and techniques used as complementary and alternative approaches for oral health care. A comprehensive electronic database search was conducted in PubMed, CINAHL, MEDLINE, EMBASE, Google, Google Scholar, and SCOPUS. Medicinal plants such as Medicago Sativa, Aloe Barbadensis Miller (Aloe Vera), and Trifolium Pratense (Red Clover) have excellent applications in treating gum disorders, prevent tooth decay, and have demonstrated good antifungal activity in the oral cavity. Homeopathic medicines such as Belladonna, Antimonium crudum , and Chamomilla have useful applications in relieving toothache. In Chinese medicine, various acupressure points (Acupuncture) have been used to relieve pain related to tooth, head-and-neck region, sinusitis, etc. Dental professionals can utilize these treatment modalities in their practice along with other conventional procedures as an integrative treatment approach to achieve better outcomes.
Abstract licence: CC BY-NC-SA
D. Shinde, Dr.Sweta Sahoo, D. A. G. Namdeo, et al.
International Journal of High Dilution Research - ISSN 1982-6206, 2025
ABSTRACT Aim: This study aims to investigate the potential of homoeopathic remedy Calcarea Phosphorica in enhancing the biosynthesis of secondary metabolites in endangered medicinal plant Psoralea corylifolia (L.) Background: Psoralea corylifolia (L.) Medik., often known as Babchi, is a medicinal plant from the Fabaceae family. It has been extensively utilized in traditional medicine to treat an array of dermatological disorders, such as psoriasis, leprosy, and vitiligo Beyond its traditional use for skin conditions, Psoralea corylifolia (L.) possesses various other properties, including antioxidant, anticancer, hepatoprotective, antimycobacterial, antidiabetic, anthelminthic, and anti-inflammatory effects. This versatility is attributed to the presence of potent secondary metabolites, including furanocoumarins and isoflavonoids. However, unsustainable harvesting practices pose a significant threat to the plant's survival. Tissue culture offers a promising avenue for sustainable production of valuable medicinal compounds. Interestingly emerging research suggests the potential of homeopathy to enhance the production of secondary metabolites. Methods: This study explores the potential of the homeopathic remedy Calcarea phosphorica at various potencies (6CH, 12CH, 30CH, 200CH, 1M), both alone and in combination with plant growth regulators, on the growth, callus induction, and psoralen quantity in Psoralea corylifolia (L.). The process involves several stages: callus induction, shoot regeneration, shoot multiplication, rooting of elongated shoots, and hardening. Finally, psoralen production was analyzed using High-Performance Liquid Chromatography (HPLC). Results: The highest fresh weight of callus was achieved with 0.5 ml/l Calc Phos 1M. The combined usage of 0.5 ml/l Calc Phos 1M + 1.0 mg/l 2,4-D + 0.5 mg/l KN resulted in the greatest fresh and dry callus weights. Increasing the strength of Calcarea phosphorica significantly increased psoralen content, with the greatest observed (2481.4 µg/g fresh wt.) in cultures treated with 1.0 ml/l Calc Phos 1M. Particularly, 1.0 ml/l Calc Phos 1M coupled with 1.0 mg/l 2,4-D and 0.5 mg/l KN yielded the highest psoralen in the culture. Conclusion: The findings indicate that the homeopathic remedy Calcarea Phosphorica can enhance the production of secondary metabolites in Psoralea corylifolia (L.). This research highlights the potential of homeopathic approaches for optimizing in vitro cultivation of medicinal plants, a long-standing technique that improves both yield and phytochemical composition.
Abstract licence: CC BY-NC-SA
D. Chatterjee, Krishnendu Paira, Satadal Das
Research Journal of Biotechnology, 2025
M. C. Pereira, Thainá Beatriz Soares, J. Stroparo, et al.
DNA and Cell Biology, 2026
- Homeopathy
- Materia Medica
- Plant Extracts
R. Madsen
Homoeopathic Links, 2023
S. DINESH KUMAR, K. Mohamed Abudhahir, N. Selvamurugan, et al.
Materials science & engineering. C, Materials for biological applications, 2018
- Ceramics
- Osteogenesis
- Tissue Engineering
Sources: aggregated from Europe PMC (EMBL-EBI), OpenAlex, Crossref, PubMed and other open scholarly databases. Retracted articles are excluded. Study information is provided for research purposes and does not constitute medical advice.
Scientific data (pharmacology, interactions, ADME) is not yet available for this medicine. Clinical sections are sourced from the NHS dm+d database.